Kurs
+3,81%
Kurs
+3,81%
Open
11,77
High
11,77
Low
10,77
Close
11,77
Kursutveckling under dagen för detta pressmeddelande
(NOK).
Kalender
| Tid* | ||
| 2025-08-29 | 07:00 | Kvartalsrapport 2025-Q2 |
| 2025-05-28 | N/A | Årsstämma |
| 2025-03-18 | 21:30 | Bokslutskommuniké 2024 |
| 2025-01-07 | N/A | Extra Bolagsstämma 2025 |
| 2024-08-26 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-27 | - | X-dag ordinarie utdelning OBSRV 0.00 NOK |
| 2024-05-24 | - | Årsstämma |
| 2024-03-13 | - | Bokslutskommuniké 2023 |
| 2023-11-22 | - | Extra Bolagsstämma 2023 |
| 2023-08-25 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-30 | - | X-dag ordinarie utdelning OBSRV 0.00 NOK |
| 2023-05-26 | - | Årsstämma |
| 2023-02-17 | - | Bokslutskommuniké 2022 |
| 2022-11-03 | - | 15-10 2022-Q3 |
| 2022-08-25 | - | Kvartalsrapport 2022-Q2 |
| 2022-06-03 | - | Årsstämma |
| 2022-06-03 | - | X-dag ordinarie utdelning OBSRV 0.00 NOK |
| 2022-03-29 | - | Bokslutskommuniké 2021 |
| 2022-02-04 | - | Extra Bolagsstämma 2022 |
| 2021-11-03 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-20 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-25 | - | X-dag ordinarie utdelning OBSRV 0.00 NOK |
| 2021-05-21 | - | Årsstämma |
| 2021-05-12 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-23 | - | Bokslutskommuniké 2020 |
| 2020-11-03 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-18 | - | Kvartalsrapport 2020-Q2 |
| 2020-07-01 | - | X-dag ordinarie utdelning OBSRV 0.00 NOK |
| 2020-06-30 | - | Årsstämma |
| 2020-06-16 | - | Extra Bolagsstämma 2020 |
| 2020-05-12 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-25 | - | Bokslutskommuniké 2019 |
Beskrivning
| Land | Norge |
|---|---|
| Lista | OAX Equities |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
2021-05-20 17:27:57
Oslo, 20 May 2021: In connection with the annual general meeting of Observe
Medical ASA (the "Company") to be held on 21 May 2021 (the "AGM"), Terje Bakken,
chairman of the board of directors of the Company, has as at the close of
trading on the Oslo Stock Exchange on 20 May 2021, received proxies without
voting instructions for 1,576,864 shares or 8.04% of the total shares and voting
rights in the Company. The proxies are only valid at the AGM.
In addition, Terje Bakken represents Ingerø Reiten Investment Company AS at the
board of directors of the Company, who holds 3,939,394 shares or 20.09% of the
total shares and voting rights in the Company. Hence, following the receipt of
the proxy, Terje Bakken controls 28.14% of the total shares and voting rights in
the Company at the AGM.
This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.